The company, which also manufacturers a range of other skin care, personal care and acne products, will now start to distribute its portfolio with CSB Drogaria, which operates two retail pharmacy chains – Drogasmil and Farmalife, giving it a combined exposure to 85 retail outlets throughout the country.
Likewise, CSB Drogaria is owned by Profarma, a leading distributor to pharmacies throughout Brazil, and is estimated to distribute 18 million units per month in more than 31,000 sales outlets, giving it an estimated 93 percent coverage of the pharmaceutical market in Brazil.
DS Healthcare expects to see a rapid increase in Brazil sales
Tapping into this distribution network, DS Healthcare says it is expecting to see a rapid expansion of its sales in the country as its product distribution continues to expand.
"Our 10 best-selling SKUs which are approved for commercialization and distribution are currently being sold in the Brazilian market. This includes our leading hair loss products.” said DS Healthcare President and CEO Daniel Khesin.
"We plan on receiving further regulatory approvals as sales begin to accelerate… Based on the success of this pilot program, we expect to continue to expand throughout Profarma's network, one of the biggest distributors in Brazil."
Within the product portfolio, DS Healthcare has four principle brands – the flagship DS Laboratories, men’s grooming brand Sigma Skin, physicians brand Polaris Research, organic line The Pure Guild and Omega supplements line Nutra Origin.
Pushing the flagship brand
The company is expected to give the biggest push to its DS Laboratories brand, which includes the Revita and Spectral hair regrowth lines, as well as general hair and skin care lines, personal care and facial anti-aging treatments.
The market for cosmetics and personal care has gone from strength to strength in recent years, consistently returning double digit annual growth.
Much of this growth has been fuelled by women entering the employment pool, which in turn has translated into a considerably higher expendable income, and one that has invariably trickled down into an increase spend on personal care regimes.
In 2011 market researcher Euromonitor estimated that the Brazilian beauty industry generated sales of approximately $43 billion, which represented an increase of 19 percent on the value for the previous year.